Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
HumanPhenoThoracic platyspondyly

FLNB PLCB3

2.42e-05672HP:0004592
DomainActinin_actin-bd_CS

FLNB SYNE2

3.94e-0423242IPR001589
DomainACTININ_2

FLNB SYNE2

3.94e-0423242PS00020
DomainACTININ_1

FLNB SYNE2

3.94e-0423242PS00019
DomainCH

FLNB SYNE2

3.13e-0365242SM00033
DomainCH

FLNB SYNE2

3.62e-0370242PF00307
Domain-

FLNB SYNE2

3.73e-03712421.10.418.10
DomainCH

FLNB SYNE2

3.93e-0373242PS50021
DomainCH-domain

FLNB SYNE2

4.15e-0375242IPR001715
Domain-

FLNB CD3G PILRA IL5RA

9.50e-036632442.60.40.10
DomainIg-like_fold

FLNB CD3G PILRA IL5RA

1.18e-02706244IPR013783
Pubmed

Association study of frameshift and splice variant polymorphisms with risk of idiopathic recurrent pregnancy loss.

MS4A14 ABCB5

1.87e-06328229956771
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

CEP350 ANKRD36B CKAP2L PRPF19 SCAF11 KHDRBS3 TUT7

8.32e-05137128736244648
Pubmed

Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.

PLCB3 CD3G

9.49e-05182821979339
Pubmed

CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.

PRPF19 SYNE2

9.49e-051828233361760
Pubmed

An Alternative Splicing Program for Mouse Craniofacial Development.

FLNB SYNE2

1.30e-042128233013468
Pubmed

Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis.

SELP IL5RA

3.25e-043328218974840
Pubmed

Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay.

SELP IL5RA

3.25e-043328219028820
Pubmed

Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism.

SELP IL5RA

3.45e-043428220603037
Pubmed

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.

SELP RBL2 IL5RA

3.99e-0417928319074885
Pubmed

Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences.

SELP PLCB3

4.32e-043828210501973
Pubmed

Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.

ANKRD36B ANKRD36 SYNE2

4.54e-0418728326460568
Pubmed

Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2.

FLNB ANKRD36

6.06e-044528227337956
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

ANKRD36B ANKRD36 ANKRD36C RIPK1 RBL2

7.23e-0491028536736316
InteractionCSNK2A3 interactions

ANKRD36B ANKRD36 ANKRD36C RIPK1

1.56e-05110284int:CSNK2A3
CytobandEnsembl 112 genes in cytogenetic band chr2q11

ANKRD36B ANKRD36 ANKRD36C

1.12e-04153283chr2q11
Cytoband11q12.2

PRPF19 MS4A14

2.62e-043928211q12.2
Cytoband2q11.2

ANKRD36B ANKRD36

8.93e-04722822q11.2
CytobandEnsembl 112 genes in cytogenetic band chr11q12

PRPF19 MS4A14

1.87e-02345282chr11q12
GeneFamilyAnkyrin repeat domain containing

ANKRD36B ANKRD36 ANKRD36C

2.28e-03242203403
GeneFamilyADAM metallopeptidase domain containing|CD molecules

SELP CD3G IL5RA

8.89e-03394203471
CoexpressionGSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP

CEP350 CD3G RBL2 TUT7

2.89e-05167284M2995
CoexpressionGSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP

MS4A14 CCDC168 PILRA LINC02915

5.18e-05194284M8674
CoexpressionGSE29618_PDC_VS_MDC_UP

ANKRD36B FLNB ANKRD36 SYNE2

5.61e-05198284M4951
CoexpressionGSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN

CKAP2L RAB11FIP4 RIPK1 RBL2

5.72e-05199284M6351
ToppCellCOVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CD3G ANKRD36 ANKRD36C RBL2 SYNE2

1.32e-071952854bdedd924564a260841a9153604026b57487c83d
ToppCellCOVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

CD3G ANKRD36 ANKRD36C RBL2 SYNE2

1.39e-07197285c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCellsystemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

SCAF11 CD3G ANKRD36 RBL2 SYNE2

1.42e-071982854c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

ANKRD36B ANKRD36 ANKRD36C SYNE2

2.34e-06151284999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCellnormal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

2.60e-0615528408295584395e8d9cfc1b1648f98754b3ac53e587
ToppCellCOVID-19_Moderate-multiplets|World / disease group, cell group and cell class

ANKRD36B ANKRD36 ANKRD36C SYNE2

2.67e-06156284afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue

ANKRD36B ANKRD36 ANKRD36C SYNE2

4.81e-06181284f2315414e714ac86211546a935660c4be6e85f1b
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36 RBL2 SYNE2

5.02e-06183284f2ef110bf29b1a8276ef216238363e542db262c1
ToppCell(1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)

CD3G ANKRD36C RBL2 SYNE2

5.59e-06188284b8f67ac2faadd5b848955e43ab5d6cf5e49b3681
ToppCellASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

CD3G ANKRD36 ANKRD36C SYNE2

5.71e-06189284f5dc500f77f04a110dd4a65cf4c03068a495dbdb
ToppCellNS-critical-d_0-4-Lymphoid-CTL|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD3G ANKRD36 RBL2 SYNE2

5.71e-06189284fb7572fb4c7c43886d57a025decad076f32a14c4
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36C RBL2 SYNE2

5.83e-0619028491ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD36B CD3G ANKRD36 SYNE2

5.83e-06190284d153a0bdedcd6865e6ee19575234a78b5d859ff1
ToppCellNS-critical-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD3G ANKRD36 RBL2 SYNE2

5.83e-0619028484f9f5ac29ff0f929a589b76efa61d4c570e76b0
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36C RBL2 SYNE2

5.95e-06191284696921a4f160b6b55698652488ed781e855e5e51
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36C RBL2 SYNE2

5.95e-06191284d9a6f61fcda4f5352488f7f55cb9b57aeacc717f
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CKAP2L CD3G RBL2 SYNE2

5.95e-06191284912e2d10d3423aa7f708fcf2b11da1845f12d7d3
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CKAP2L CD3G RBL2 SYNE2

5.95e-0619128477a2746b6d9c53b08d4405411c16fcc5a6c734ce
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.07e-06192284e07b6892276c81c1227e94ca942f6820d89a7ca3
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.07e-06192284ed1fb700d3e8f00495727d61e164fc0b70274fd0
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.07e-061922846779b0294bb058e748e22b795b6a381c4add37e9
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

ANKRD36B ANKRD36 ANKRD36C SYNE2

6.07e-0619228447646d7e4990be85072987f92bf18d52f8da752e
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.33e-061942849588a9b4baebbae08e13d201d4b9dfcf0e6521fb
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.33e-061942840b0042b6a356a49a059fb64a1e1abb25c82d48cf
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.46e-061952845001e68df2ad5df9dc93ae235f984ffafea6b521
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.46e-0619528407035a5972a78b98e4ab2167e3a5000f9f3b0826
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.46e-0619528453528e5788083bce5a8d4611ab3808878e6a9cd3
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36 ANKRD36C SYNE2

6.46e-06195284ed5f772c82d4dfd1c8735224446ec9feae3fb8c2
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36C RBL2 SYNE2

6.59e-06196284c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.72e-061972842e9677b4b9a7c88db16416e5f114a2031ec3bc24
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 RBL2 SYNE2

6.72e-061972844c9919914079e76b1d2220b249e0d0b0d9bf4bc0
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

CEP350 ANKRD36 ANKRD36C TUT7

6.72e-061972840fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellNS-critical-LOC-Lymphoid-CTL|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD3G ANKRD36 RBL2 SYNE2

6.86e-06198284e2acb074142aa62c763139bbcf36f6f85038d04b
ToppCell(10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition

CEP350 ANKRD36B ANKRD36 SYNE2

7.00e-0619928461b1ed2db71b96157b92b7535d1955a4033098da
ToppCellCOVID-19_Moderate|World / disease group, cell group and cell class

ANKRD36B CD3G ANKRD36C SYNE2

7.00e-06199284952fac67588ad5676f5939e3c7f8bac803c27064
ToppCellSepsis-Int-URO-Lymphocyte-T/NK-CD4+_Tem|Int-URO / Disease, condition lineage and cell class

CD3G ANKRD36C IL5RA SYNE2

7.00e-06199284c55634d4b66ab4e3f9262a83d993ea0c5f01ea61
ToppCellCOVID-19_Moderate-CD4+_CTL|World / disease group, cell group and cell class

CD3G RBL2 IL5RA SYNE2

7.00e-0619928412ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6
ToppCellControl_saline-Hematopoietic_Myeloid-Granulocytic_cells|Control_saline / Treatment groups by lineage, cell group, cell type

RAB11FIP4 PILRA IL5RA TUT7

7.00e-06199284a4d6525e70de39802ff9fdef0d877c4463a6200d
ToppCellhealthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass

CD3G ANKRD36 RBL2 SYNE2

7.00e-061992842841e16d54acd344ba454f024e285c28abc37319
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

ANKRD36 ANKRD36C SYNE2

5.92e-0512128319333a660800b583fa27b495c1f7828e6636a257
ToppCell3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

ANKRD36 ANKRD36C SYNE2

8.19e-05135283ae2d3a42e567b5bade304c0caa497eb725be3565
ToppCellNS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ANKRD36 ANKRD36C ARHGEF16

8.56e-0513728303e124901a0e85b59b6882bbafab568b50907e8b
ToppCellmoderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ANKRD36 ANKRD36C ARHGEF16

8.74e-05138283afefa8233c67aa744e939156bc538449bf6bd05b
ToppCellNS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ANKRD36 ANKRD36C ARHGEF16

9.32e-0514128333ad925ff7be3c682741a6328216a89f9d4033e9
ToppCell368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells)

CCDC168 CD3G SYNE2

1.05e-04147283743767abdb3b5ecad870b617f515b037ce280818
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CD3G ANKRD36 SYNE2

1.12e-04150283c922dbb4c9c12ccf08bd5f6168b20606c605d052
ToppCellCOVID-19_Mild-PLT_5|World / Disease Group and Platelet Clusters

KIAA1755 CD3G SYNE2

1.16e-0415228390ba4e8a735ec8921038fa072129535f0e3fd9ae
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FLNB CD3G SYNE2

1.16e-04152283405d19b290232bb3e564d61c0cff0cfdd247bdff
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FLNB CD3G SYNE2

1.16e-0415228306fa7d8acc8f56de00af9bee17884595b300410e
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

FLNB CD3G SYNE2

1.19e-04153283b101cb1bce5db785dab46b6c4f7be9c3efe48b0e
ToppCellPBMC-Severe-Lymphocyte-T/NK-Other_T-dn_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

FLNB CD3G SYNE2

1.19e-04153283487388082bb596809ba1caf9197626b6814792ab
ToppCellPBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters

CD3G ABCB5 SYNE2

1.19e-041532834ee37266b0054f276c7a73ab9220f681b9d74c71
ToppCellfacs-Pancreas-Exocrine-24m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD3G PILRA IL5RA

1.23e-041552836ade33c274d35ae5531956f70526005d1d5e277b
ToppCellfacs-Pancreas-Exocrine-24m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD3G PILRA IL5RA

1.23e-04155283c465a22abc2b9705b6b0fc4753980f790ab8ec5e
ToppCellfacs-Pancreas-Exocrine-24m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD3G PILRA IL5RA

1.23e-041552830dec58d76e3f8cff9d62eaa4adb21a1dc7fd7487
ToppCellCOVID-19_Severe-Lymphoid_T/NK-dn_T|COVID-19_Severe / Disease group, lineage and cell class

FLNB CD3G SYNE2

1.26e-0415628383f25683e0f55472b56f915ee176fc05efc33a31
ToppCell10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue

ANKRD36B ANKRD36 SYNE2

1.26e-0415628310d191e29b16cae8238e8df6c0ff38882253f34e
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue

ANKRD36 ANKRD36C SYNE2

1.26e-041562831545169694f686d28648a68b552c2ae606599d66
ToppCell3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue

CD3G IL5RA SYNE2

1.28e-04157283af6eb2214340847bbab7cb209ea27cdc83b62a27
ToppCellfacs-GAT-Fat-24m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AKAP4 CD3G IL5RA

1.28e-04157283c4a0b6c95d353691fd2846002ce4bc7c2b0edd1c
ToppCell10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue

ANKRD36B ANKRD36C SYNE2

1.41e-04162283b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G ANKRD36 SYNE2

1.41e-0416228380317c4253bf8e897782e562f29835f181c65b98
ToppCellLeuk-UTI-Lymphocyte-T_NK-CD4_TEM|Leuk-UTI / Disease, Lineage and Cell Type

CD3G IL5RA SYNE2

1.48e-0416528308285c09de16ed4f488abb655a22f54bc07968ae
ToppCellfacs-Heart-RA-24m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD3G PILRA IL5RA

1.48e-04165283995f1524965a4314938f27165166f0aaff9dea02
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ANKRD36 ANKRD36C SYNE2

1.54e-0416728383969c36ac44b96afc9aa09400a99fa2b487f7ff
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

PTGR2 CD3G SYNE2

1.56e-041682835e721268f0baa51d3f640f7f4c41db769ebef210
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G RBL2 SYNE2

1.56e-04168283b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff
ToppCellsevere_influenza-CD4+_CTL|severe_influenza / disease group, cell group and cell class (v2)

CD3G IL5RA SYNE2

1.56e-0416828350697fda702a09d9a621e9f79c2b52d53792dd2a
ToppCellInt-URO-Lymphocyte-T_NK-CD4_TEM|Int-URO / Disease, Lineage and Cell Type

CD3G ANKRD36C SYNE2

1.59e-041692835b2fb89cbc9b92d609994d6e5aa35a67c3cc8f22
ToppCellnormal_Pleural_Fluid-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass

CD3G ANKRD36 SYNE2

1.59e-04169283bea8aba1f3cc3d0e8d448c1c45f5354d26ebf850
ToppCellICU-NoSEP-Lymphocyte-T_NK-CD4_CTL|ICU-NoSEP / Disease, Lineage and Cell Type

CD3G RBL2 SYNE2

1.59e-04169283cbda36f32bd78322dcfe303a44413415d08e5ea3
ToppCellCOVID-19_Severe-CD4+_CTL|World / disease group, cell group and cell class

CD3G IL5RA SYNE2

1.59e-041692838c8168ac93a808d7b4756e4491db2b2979df1c1f
ToppCellSevere-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass

CD3G RBL2 SYNE2

1.62e-041702835788e1158fde036937d41708e9db3222ca351eb1
ToppCellPND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SELP CKAP2L FLNB

1.62e-041702837534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD3G RBL2 SYNE2

1.65e-04171283e1fe07652c10c37191d1471ddaea500f74269e0c
ToppCellnormal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 SYNE2

1.65e-0417128361318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

ANKRD36 ANKRD36C SYNE2

1.65e-041712832e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 SYNE2

1.68e-041722839497948bbe53fb88c6ff6b347f743d456da587e5
ToppCellmild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2)

ANKRD36B CD3G SYNE2

1.71e-04173283b6615ff02f5017d7150b1e33b53f8c7a26081a0d
ToppCellPND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SELP FLNB RIPK1

1.71e-041732834968712af1cca8c932abd3323631d7dcaffd4a66
ToppCell5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ANKRD36B ANKRD36 IL5RA

1.76e-041752836a093c74a6f3daeff07759d6eec542fc5c709149
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CD3G RBL2 SYNE2

1.76e-041752838269721389a3ce98681460e6393f2cff816eaa25
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CKAP2L CD3G SYNE2

1.76e-0417528316c835e62a3321f6cf6163954889946bbb869498
ToppCellHealthy_Control-Lymphoid-T-Treg|Healthy_Control / Condition, Lineage, Cell class and cell subclass

SELP CD3G SYNE2

1.79e-041762837765a5b04ac117d525201f8eb08e1754e55942ff
ToppCellCOVID-19_Severe-CD4+_CTL|COVID-19_Severe / disease group, cell group and cell class

CD3G IL5RA SYNE2

1.82e-0417728334e9455790bae905dd91923792f4109d18b7686e
ToppCelldroplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCAF11 TUT7 SYNE2

1.85e-0417828301dafd19de04eff459253eaa9a35debf8f3deedf
ToppCellfacs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKAP2L PILRA SYNE2

1.85e-0417828315a99080e9f669572ab6d82934f324e6714846c1
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 SYNE2

1.85e-0417828390dedb3cef9b01907b9f8eec64218d6d2072be1f
ToppCellfacs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKAP2L PILRA SYNE2

1.85e-04178283200308e109abb7e6f8816a6f8cce6d56862d4098
ToppCellsystemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 SYNE2

1.85e-04178283d6312286bf6cc5b107ccd7adb583d9667d4e1d21
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

CD3G RBL2 SYNE2

1.85e-0417828331c847d7f7aa0f6d820afbb45d507992f5e9dc2f
ToppCellMild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass

CD3G RBL2 SYNE2

1.89e-04179283abc0fbe101a464a2c85755a974a3d5c2b968fe46
ToppCellsevere-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

FLNB IL5RA SYNE2

1.92e-04180283ac03812b1409435c55d323a7516deeac82bd3509
ToppCellCOVID-19-T_cells-Tregs|COVID-19 / group, cell type (main and fine annotations)

SELP CD3G SYNE2

1.95e-04181283534659cf754326c6a73c0daa30e9d610612a0292
ToppCellCOVID-19_Mild|World / Disease Group and Platelet Clusters

LINC02915 TUT7 SYNE2

1.98e-0418228390c61e10c7860bfba6ccfe6f37671c8924637f7b
ToppCellURO-Lymphocyte-T_NK-dnT|URO / Disease, Lineage and Cell Type

FLNB ANKRD36C SYNE2

1.98e-04182283f2b1c524301d0f2d1b69c46f3653fd53c21c3aa0
ToppCellnormal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex

CD3G ANKRD36 SYNE2

2.01e-0418328379defd22b3194dad16db55b9bdd220c09c1e6b90
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MS4A14 PILRA ABCB5

2.01e-0418328302deb595819fb864a934fd0fcaad684f1ca42964
ToppCellNS-critical-d_0-4-Lymphoid-Treg|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

CD3G RBL2 SYNE2

2.01e-04183283f478dfa231fc1b12ead0183cc9d22077cdf43d1f
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

FLNB CD3G SYNE2

2.01e-04183283317b756378a9efd8ecb754acf7273f83f996e106
DiseasePR interval

KIAA1755 LINC02915 ABCB5 SYNE2

1.01e-03495274EFO_0004462
DiseaseAllergic Reaction

SELP IL5RA

1.52e-0363272C1527304
DiseaseHypersensitivity

SELP IL5RA

1.57e-0364272C0020517
Diseasetotal cortical area measurement

KIAA1755 LINC02915

3.35e-0394272EFO_0008381
Diseasechronic obstructive pulmonary disease (is_marker_for)

SELP IL5RA

3.56e-0397272DOID:3083 (is_marker_for)
Diseasecholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement

PLCB3 SYNE2

4.00e-03103272EFO_0008595, EFO_0020944
Diseasecholesterol:total lipids ratio, intermediate density lipoprotein measurement

PLCB3 SYNE2

5.47e-03121272EFO_0008595, EFO_0020943

Protein segments in the cluster

PeptideGeneStartEntry
NDQLYQPLKDREDDQ

CD3G

156

P09693
VDLYNPEGQQDQDRK

AKAP4

26

Q5JQC9
QENYQRNGTAEEQPK

ABCB5

11

Q2M3G0
DDPQLYQEIQERGLN

ARHGEF16

211

Q5VV41
KRLEEYENNQPQVKN

ANKRD36

1306

A6QL64
GEQKRLEEYENNQPQ

ANKRD36B

741

Q8N2N9
LEEYENNQPQVKNQI

ANKRD36B

746

Q8N2N9
QENYKLRDQNDDLNG

RAB11FIP4

551

Q86YS3
QDIFKYPQEEQPRQQ

RBL2

171

Q08999
GEQKRLEEYENNQPQ

ANKRD36C

1166

Q5JPF3
LEEYENNQPQVKNQI

ANKRD36C

1171

Q5JPF3
RQGDFYLQVEPQEEQ

KIAA1755

101

Q5JYT7
EEVQYIQAEKNNKGP

DDX58

36

O95786
IEGPSQAKIEYNDQN

FLNB

586

O75369
EKYIAENGTDPINNQ

PRPF19

31

Q9UMS4
IEKYEPNQQFLERDQ

PLCB3

276

Q01970
NTEEPYENIRNEGQN

PILRA

241

Q9UKJ1
KPNPDQEQRNVNLEY

IL5RA

51

Q01344
YNQEQNDTEGPKDRE

CEP350

2591

Q5VT06
AEDQQAKGEQYPEGQ

MS4A14

566

Q96JA4
EPNNKRNNEDCVEIY

SELP

121

P16109
IPDYNDEIRQAQLQE

KHDRBS3

156

O75525
KQAEQYVPRPEAEQQ

CCDC168

5611

Q8NDH2
NDRYRKNDPEKQNEN

SCAF11

981

Q99590
IDDLRYQIDDKPNNQ

MRPS30

226

Q9NP92
VELPENYNQNIKAGE

SYNE2

706

Q8WXH0
KQQPRQNVAYNREEE

RIPK1

396

Q13546
QGEYNNRHPNIKQDQ

CKAP2L

341

Q8IYA6
NQLYGEVINKETDNP

LINC02915

96

Q8N8G6
DQEDALNQRYPENKE

TUT7

1371

Q5VYS8
EEVYLPDNINEGQVQ

PTGR2

26

Q8N8N7